9 Months update - smp/min/fin/keto/derm
    Progress Pictures 4/21/2024

    From the encyclopedia
    Scalp Micropigmentation โ†’

    scalp tattoos to mimic the appearance of light stubble

    Finasteride โ†’

    Frontline, gold standard treatment for combatting androgenic alopecia

    Minoxidil โ†’

    An essential vasodilator with some anti-androgenic effects

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    ๐Ÿ’ง scalp micropigmentation (topical) 9 months
    ๐Ÿ’Š Finasteride (oral) 1mg 1x daily 9 months
    ๐Ÿ’ง Minoxidil (topical) 5mg 1x daily 9 months
    ๐Ÿ’ง derma pen (topical) 1.5mm 1x weekly 9 months
    ๐Ÿ’ง ketoconazole shampoo (topical) 9 months
    ๐Ÿ’ง low-level laser therapy (topical) daily 9 months
    ๐Ÿ’ง topical finasteride (topical) 1 month
    the tone is ๐Ÿ˜€ positive with good progress results.

    Other terms

    A user shared a 9-month hair loss treatment update using scalp micropigmentation (SMP), finasteride, minoxidil, derma pen, ketoconazole shampoo, and low-level laser therapy (LLLT), with plans for a hair transplant. Another person suggested increasing the dosage of finasteride and minoxidil and using a derma roller weekly.
    View this post in the Community โ†’

    Similar Community Posts Join

    5 / 5 results

    Related Research

    6 / 6 results
      Current Trends in Hair Care in Men

      research Current trends in hair care in men

      October 2024 in “Cosmoderma”
      In this review, the authors highlight the importance of hair care for men, suggesting that proper routines and a nutrient-rich diet can help maintain scalp health, prevent hair loss, and promote a sense of well-being.
      Scalp Micropigmentation: A Promising Camouflage Modality

      research Scalp micropigmentation: a promising camouflage modality

      June 2026 in “The Journal of Cosmetic Medicine”
      This narrative review reports that scalp micropigmentation offers immediate cosmetic improvements in hair density appearance, but does not promote actual hair regrowth and results vary based on the operator's skill.
      Androgenetic Alopecia: An Update

      research Androgenetic alopecia: An update

      July 2023 in “JAAD International”
      This study describes androgenetic alopecia as a common non-scarring hair loss condition primarily influenced by genetic factors and androgen sensitivity, notably impacting psychosocial well-being, especially in females and younger males seeking treatment.
      A Decade of Progress in Androgenetic Alopecia Management: Emerging Therapies and Multimodal Strategies

      research A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies

      December 2025 in “IP Indian Journal of Clinical and Experimental Dermatology”
      This review reports that the treatment of androgenetic alopecia is shifting from single therapies to personalized, multimodal approaches incorporating both traditional and emerging pharmacologics, regenerative strategies, nutraceuticals, cosmeceuticals, and device-based interventions, with combination regimens showing improved outcomes.
      Microneedle-Mediated Therapies in Hair Loss: Applications, Mechanisms, and Future Directions

      research Microneedle-mediated therapies in hair loss: applications, mechanisms, and future directions

      August 2025 in “Plastic and Aesthetic Research”
      This review discusses recent advancements in microneedle technology for hair loss treatment, highlighting their ability to enhance drug delivery and improve hair follicle survival in transplantation, while also exploring their potential integration with tissue engineering to address regeneration challenges.